FdaApplication
BLA 125019
Identifiers
- fda_app_no: BLA125019
Properties
| Property | Value |
|---|---|
| applicant_name | Acrotech Biopharma Inc. |
| application_type | BLA |
| approval_date | 2002-02-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZEVALIN | IBRITUMOMAB TIUXETAN | 3.2MG/2ML | INJECTABLE;INJECTION |
1 product